Graphene Biosensors — The Next Frontier In Medical Diagnostics (Graphene LIVE! USA 2014)

• Graphene Field Effect Transistors (GFETs) as a platform for sensors

• Functionalization of graphene to enhance specificity and sensitivity of detection

• Mass production of devices in semiconductor fabs

• Market applications and benefits vis-a-vis current assay technology

With a background in startup leadership, finance, and international operations, Patterson decided to pursue a MBA in Entrepreneurial Management at the Wharton School. It was there he was introduced to the potential of a little-known company with a cause: Graphene Frontiers. Since then, he has elevated the status of the business and helped usher along essential patents and research. Now, the company is poised for key partnerships and business application.

Mike is available to comment on a variety of issues including:

Founded in 2010, Graphene Frontiers is a developer of CVD graphene solutions and products, including its flagship product: the GF Six Sensor platform. The company is building on its core strengths in graphene growth, transfer, device fabrication and functionalization by creating specific products for industry use.

 

Graphene Frontiers has already vetted new technology, processes and capabilities for graphene, and they are now focused on brokering strategic partners to mass produce the "miracle material." Recently, they signed a Memorandum of Understanding to work at The Colleges of Nanoscale Science and Engineering (CNSE) at SUNY Polytechnic Institute in Albany, NY. It's a satellite location to "ramp up" production and form relationships with regional influencers at major companies.